A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy
Public ClinicalTrials.gov record NCT06384261. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multicenter, Open-label, Randomized, Phase 2 Study of Venetoclax and Azacitidine Plus Cusatuzumab Versus Venetoclax and Azacitidine Alone in Newly Diagnosed AML Patients Who Are Not Candidates for Intensive Therapy
Study identification
- NCT ID
- NCT06384261
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- OncoVerity, Inc.
- Industry
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Interventions
- Azacitidine Drug
- Cusatuzumab Drug
- Venetoclax Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 21, 2024
- Primary completion
- Dec 31, 2026
- Completion
- May 31, 2027
- Last update posted
- Sep 9, 2025
2024 – 2027
United States locations
- U.S. sites
- 17
- U.S. states
- 13
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner MD Anderson | Gilbert | Arizona | 85234 | Recruiting |
| City of Hope | Duarte | California | 91010 | Recruiting |
| University of California Los Angeles | Los Angeles | California | 90095 | Recruiting |
| University of Colorado Health - Anschutz Cancer Pavilion - Anschutz Medical Campus | Aurora | Colorado | 80045 | Recruiting |
| Yale School of Medicine | New Haven | Connecticut | 06510 | Recruiting |
| AdventHealth Medical Group Blood & Marrow Transplant at Orlando | Orlando | Florida | 32804 | Recruiting |
| The University of Iowa Hospitals & Clinics | Iowa City | Iowa | 52242 | Recruiting |
| University of Kentucky Chandler Medical Center | Lexington | Kentucky | 40536 | Recruiting |
| Norton Healthcare, Inc. | Louisville | Kentucky | 40202 | Recruiting |
| Hackensack University Medical Center | Hackensack | New Jersey | 07601 | Not yet recruiting |
| Hofstra/Northwell Health | Lake Success | New York | 11042 | Recruiting |
| Cornell University | New York | New York | 10065 | Recruiting |
| University of Rochester Medical Center | Rochester | New York | 14642 | Recruiting |
| Wake Forest North Carolina | Winston-Salem | North Carolina | 27157 | Not yet recruiting |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | Recruiting |
| Fred Hutch Seattle Cancer Care Alliance | Seattle | Washington | 98109 | Recruiting |
| Medical College of Wisonsin | Milwaukee | Wisconsin | 53226 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06384261, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 9, 2025 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06384261 live on ClinicalTrials.gov.